Jaguar Health presents at MedInvest Conference on September 19, 2024

Jaguar Health, Inc. announced that its founder, president, and CEO, Lisa Conte, will present at the MedInvest Biotech & Pharma Investor Conference on September 19, 2024. The event is scheduled to take place in New York City on September 18-19, 2024. During her presentation, Conte will discuss the company's current initiatives and future plans, providing insights into Jaguar's strategic direction and market positioning. In addition to the presentation, Lisa Conte will engage in one-on-one meetings with investors, allowing for more personalized discussions about Jaguar Health's operations and growth potential. This format is designed to foster deeper connections with potential investors and stakeholders, enhancing the company's visibility in the biotech and pharmaceutical sectors. The conference serves as a platform for companies like Jaguar Health to showcase their innovations and attract investment. Participation in such events is crucial for biotech firms, as they often rely on external funding to support research and development efforts. By presenting at this conference, Jaguar aims to highlight its advancements and secure necessary financial backing. Overall, Jaguar Health's participation in the MedInvest Conference reflects its commitment to transparency and investor engagement. The company is poised to leverage this opportunity to strengthen its relationships within the investment community and to communicate its vision for future growth.